LifePoint Health (LPNT) Given Daily News Impact Rating of 0.62

News articles about LifePoint Health (NASDAQ:LPNT) have trended very positive recently, Accern Sentiment Analysis reports. The research firm identifies positive and negative media coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. LifePoint Health earned a news sentiment score of 0.62 on Accern’s scale. Accern also gave media stories about the company an impact score of 0 out of 100, indicating that recent media coverage is extremely unlikely to have an effect on the stock’s share price in the next few days.

These are some of the media stories that may have effected Accern Sentiment’s analysis:

Shares of LifePoint Health (NASDAQ:LPNT) opened at 65.45 on Monday. LifePoint Health has a 52 week low of $50.60 and a 52 week high of $70.95. The firm has a market capitalization of $2.64 billion, a price-to-earnings ratio of 17.27 and a beta of 0.88. The stock’s 50 day moving average price is $63.46 and its 200-day moving average price is $62.00.

LifePoint Health (NASDAQ:LPNT) last released its earnings results on Friday, April 28th. The company reported $1.07 earnings per share for the quarter, topping the consensus estimate of $1.01 by $0.06. The business had revenue of $1.63 billion for the quarter, compared to the consensus estimate of $1.64 billion. LifePoint Health had a net margin of 2.26% and a return on equity of 7.06%. The firm’s quarterly revenue was up 3.1% compared to the same quarter last year. During the same period last year, the firm posted $0.85 earnings per share. Equities analysts predict that LifePoint Health will post $4.20 earnings per share for the current year.

A number of research analysts recently commented on the company. BidaskClub cut LifePoint Health from a “buy” rating to a “hold” rating in a research report on Saturday. Royal Bank of Canada restated a “buy” rating and issued a $77.00 price target on shares of LifePoint Health in a research report on Wednesday, July 5th. Zacks Investment Research upgraded LifePoint Health from a “hold” rating to a “buy” rating and set a $75.00 price target on the stock in a research report on Tuesday, July 4th. Leerink Swann upgraded LifePoint Health from a “market perform” rating to an “outperform” rating and raised their price target for the stock from $73.00 to $74.00 in a research report on Tuesday, June 6th. Finally, Morgan Stanley assumed coverage on LifePoint Health in a research report on Tuesday, June 6th. They issued an “equal weight” rating and a $65.00 price target on the stock. Two equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and five have issued a buy rating to the stock. The stock has an average rating of “Hold” and an average price target of $66.23.

TRADEMARK VIOLATION NOTICE: This article was first published by WKRB News and is owned by of WKRB News. If you are accessing this article on another domain, it was illegally stolen and reposted in violation of international copyright law. The original version of this article can be read at https://www.wkrb13.com/markets/2284517/lifepoint-health-lpnt-given-daily-news-impact-rating-of-0-62.html.

In related news, Chairman William F. Carpenter III sold 82,347 shares of the firm’s stock in a transaction that occurred on Thursday, June 15th. The shares were sold at an average price of $64.15, for a total transaction of $5,282,560.05. Following the completion of the sale, the chairman now directly owns 504,535 shares in the company, valued at $32,365,920.25. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Richard H. Evans sold 2,000 shares of the firm’s stock in a transaction that occurred on Thursday, May 11th. The stock was sold at an average price of $62.88, for a total transaction of $125,760.00. Following the sale, the director now owns 17,718 shares of the company’s stock, valued at $1,114,107.84. The disclosure for this sale can be found here. Company insiders own 7.28% of the company’s stock.

About LifePoint Health

LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.

Insider Buying and Selling by Quarter for LifePoint Health (NASDAQ:LPNT)

This story was originally published by WKRB News (https://www.wkrb13.com) and is the sole property of WKRB News. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at https://www.wkrb13.com/markets/2284517/lifepoint-health-lpnt-given-daily-news-impact-rating-of-0-62.html

Receive News & Ratings for LifePoint Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

 


Leave a Reply

 
© 2006-2017 WKRB News.